Wellington Shields Capital Management, LLC Repligen Corp Transaction History

Wellington Shields Capital Management, LLC

  • $1.23 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $27,756 - $35,302
-200 Reduced 8.0%
2,300 $365,000
Q3 2021

Nov 10, 2021
SELL
$194.77 - $324.21 $126,600 - $210,736
-650 Reduced 20.63%
2,500 $722,000
Q1 2021

May 12, 2021
BUY
$180.37 - $226.26 $36,074 - $45,252
200 Added 6.78%
3,150 $612,000
Q4 2020

Feb 09, 2021
SELL
$148.08 - $206.57 $14,808 - $20,657
-100 Reduced 3.28%
2,950 $565,000
Q3 2020

Nov 10, 2020
BUY
$122.51 - $158.27 $373,655 - $482,723
3,050 New
3,050 $450,000

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
54.9M
Call Options Held
297K
Put Options Held
343K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wellington Shields Capital Management, LLC Portfolio

Follow Wellington Shields Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email